Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -2022/23 group results

May 11 (Reuters)- 
          Takara Bio Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           78.14           67.70          53.30        22.80    
               (+15.4 pct)     (+46.9 pct)    (-31.8 pct)  (-30.0 pct) 
  Operating       20.54           28.90           8.00         2.10    
               (-28.9 pct)    (+107.1 pct)    (-61.1 pct)  (-80.7 pct) 
  Recurring       20.68           28.46           8.20         2.10    
               (-27.3 pct)    (+101.0 pct)    (-60.4 pct)  (-80.8 pct) 
  Net
  Net             16.01           19.85           5.50         1.20    
               (-19.3 pct)    (+107.9 pct)    (-65.7 pct)  (-85.9 pct) 
  EPS          132.97 yen      164.84 yen      45.67 yen     9.96 yen  
  Ann Div       42.00 yen       33.00 yen      17.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       42.00 yen       33.00 yen      17.00 yen               
  
  NOTE - Takara Bio Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news